The Direct-to-consumer Testing Market is expected to witness a strong In Upcoming Years. The ongoing trend speaks of digital transformation. In other words, it’s about the provision of digital solutions being tabled all across. The big thing is that the key stakeholders can’t afford to keep digital technology in a silo. Unification is the need of the hour so that anytime-anywhere access is possible. The enterprise is slated to move with the same mindset in the forecast period.
Direct-to-consumer tests are In vitro diagnostics test which are directly marketed to consumers without the involvement of a health care provider. These tests required the user to collect a sample, such as urine or saliva, and send it to the company for testing and analysis.
Various types of Direct-to-consumer tests are available, for instance, complete chemistries, blood counts, thyroid and hormone analysis, enzymes, diabetes, lipid panels, heavy metals (lead, arsenic), cancer screening, drugs of abuse, sports doping and steroids, therapeutic drug monitoring, pregnancy, fertility, inflammatory bowel syndrome, Crohn’s disease, and sexually transmitted diseases.
There are thousands of Direct-to-consumer tests currently available with more being developed. Moreover, patient with sexually transmitted diseases are not being tested due to due to fear, shame, stigma and embarrassment.
However, Direct-to-Consumer Tests remove barrier to laboratory testing for sexually transmitted diseases, Patient can have test with privacy. Moreover, COVID-19 will show negative impact on Direct-to-consumer tests due to short time shut down of production facilities as well as significant disruption in supply chain.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32472
Rising awareness and adoption of direct-to-consumer tests among general people will propel the direct-to-consumer test market growth over the forecasting period. Leading players are focusing on developing easy to use direct-to-consumer testing solutions with superior quality. These tests ensure to provide efficient and accurate genetic test results.
Furthermore, growing technological advancement in direct-to-consumer tests will fuel the growth of direct-to-consumer testing market. Beside, leading players offers direct-to-consumer testing kits through online channels to market their products.
This allows key players to reach to a broad customer base across the world. Moreover, direct-to-consumer testing helps to avoid waiting for an appointment with doctors which also one the major factor for adaption of direct-to-consumer test.
However, direct-to-consumer testing still have a patient data privacy issue. Beside that many direct-to-consumer test are not covered in insurance plan which can hinder the direct-to-consumer testing market growth.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32472
Direct-to-consumer Testing Market: Segmentation
A Direct-to-consumer Testing market can be segmented into test type, technology, distribution channels and geography.
Based on test type, the global Direct-to-consumer Testing market is segmented as:
- Carrier Screening Tests
- Genetic Health Risk (GHR) Tests
- Pharmacogenetics Tests
- Cancer Predisposition Tests
- Low Risk General Wellness Tests
- Ancestry Tests
- Nutrigenomics Testing
Based on technology, the global Direct-to-consumer Testing market is segmented as:
- Targeted Analysis
- Single Nucleotide Polymorphism (SNP) Chips
- Whole Genome Sequencing (WGS)
Based on the distribution channels, the global Direct-to-consumer Testing market is segmented as:
- Online Platforms
- Over-the-Counter
A Direct-to-consumer Testing market is expected to show remarkable growth over the forecast period due to rising adaption of Direct-to-consumer test amongst the people. Moreover, key players are focusing on development of easy to use and cost effective direct-to-consumer test.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32472
Based on test type segment, cancer predisposition tests is expected to hold the major market share in a Direct-to-consumer Testing market due rising prevalence of cancer. Among technology segment, Single Nucleotide Polymorphism (SNP) Chips segment is expected hold highest revenue generating segment.
Geographically, North America is a significant region in a Direct-to-consumer Testing market due to rise in adaption of direct-to-consumer test in this region. Europe hold second largest share in region due to upsurge in demand for direct-to-consumer test in this region.
Moreover, East Asia and South Asia region will show significant market growth rate due to rising demand for direct-to-consumer testing options. Furthermore, due to poor healthcare facilities and lower adaption of direct-to-consumer testing in Middle East and Africa is expected to be least-lucrative market.
The global market for Direct-to-consumer Testing is consolidated with few market players. Examples of some of the primary key players operating in the global Direct-to-consumer Testing market are 23 and Me, Genesis Healthcare., Pathway genomics., MyHeritage., Mapmygenome., Living DNA, Karmagenes, Identigene, Helix OpCo LLC, Full Genome Corporation, Easy DNA, Color Genomics, Ancestry and among others.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com